The Screening Tomosynthesis Trial with Advanced Reader Methods (STREAM): design and rationale of a population-based breast cancer screening trial - Summary - MDSpire

The Screening Tomosynthesis Trial with Advanced Reader Methods (STREAM): design and rationale of a population-based breast cancer screening trial

  • By

  • Lindy Kregting

  • Daan van den Oever

  • Lian Pennings

  • Ruud Pijnappel

  • Nicolien van Ravesteyn

  • Ellen Verschuur

  • Marja van Oirsouw

  • Loes Dunning

  • Hans ‘t Mannetje

  • Ruben van Engen

  • Adriana Bluekens

  • Maartje Smid-Geirnaerdt

  • Cary van Landsveld-Verhoeven

  • Nehmat Houssami

  • Ioannis Sechopoulos

  • Mireille Broeders

  • January 9, 2025

  • 0 min

Share

Objective:

To determine the outcomes and cost-effectiveness of nationwide digital breast tomosynthesis (DBT) breast cancer screening in the Netherlands using optimal image acquisition and interpretation strategies, including specific methods to be evaluated.

Key Findings:
  • DBT has shown improved cancer detection rates in studies but no significant effect on interval cancer rates, raising questions about its necessity in a high-performing screening program.
  • The Dutch programme's current detection rate is already high, prompting a need to evaluate the added value of DBT.
  • Optimizing DBT interpretation is crucial for feasibility in terms of economic and human resources, which may influence implementation.
Interpretation:

The STREAM trial aims to assess whether DBT can enhance breast cancer screening outcomes in the Netherlands while maintaining cost-effectiveness and stakeholder acceptability, potentially shaping future screening practices.

Limitations:
  • Exclusion of wheelchair-bound individuals may limit generalizability, as this group may have different screening needs.
  • Potential increase in recall rates with DBT is uncertain, necessitating further investigation.
Conclusion:

The STREAM trial will provide valuable insights into the effectiveness and acceptability of DBT in breast cancer screening, potentially influencing future screening practices in the Netherlands.

Original Source(s)

Related Content